Market closedADR

GENFIT/$GNFT

14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX

About GENFIT

Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of innovative medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.

Ticker

$GNFT
Trading on

Industry

Biotechnology
Headquarters

Employees

169

GENFIT Metrics

BasicAdvanced
$187M
Market cap
8.35
P/E ratio
$0.46
EPS
1.09
Beta
-
Dividend rate
$187M
1.09
$6.24
$3.31
7.2K
3.744
3.642
61.405
69.64
4.31%
6.51%
25.91%
8.354
2.254
1.83
3.53
-4.241
175.45%
-163.31%
136.69%
-22.81%

What the Analysts think about GENFIT

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for GENFIT stock.

GENFIT Financial Performance

Income Statement

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

GENFIT Earnings Performance

Earnings per share (EPS)

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $GNFT

$

Sign up or log in to buy
Capital at risk
Market closedADR

Upcoming events

No upcoming events

FAQs

What’s the current market cap for GENFIT stock?

GENFIT (GNFT) has a market cap of $187M as of December 14, 2024.

What is the P/E ratio for GENFIT stock?

The price to earnings (P/E) ratio for GENFIT (GNFT) stock is 8.35 as of December 14, 2024.

Does GENFIT stock pay dividends?

No, GENFIT (GNFT) stock does not pay dividends to its shareholders as of December 14, 2024.

When is the next GENFIT dividend payment date?

GENFIT (GNFT) stock does not pay dividends to its shareholders.

What is the beta indicator for GENFIT?

GENFIT (GNFT) has a beta rating of 1.09. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.